Evidence map›Paper›PMID 15860863›Full record

Trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology2005

Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer.

Kathleen Ell, Kathleen Sanchez, Betsy Vourlekis, Pey-Jiuan Lee, Megan Dwight-Johnson, Isabel Lagomasino, Laila Muderspach, Christy Russell

Registry-linked trialOpen access · bronzeAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04219267 (Effectiveness of Character Strengths-based Intervention in Enhancing Self-esteem, Quality of Life and Alleviating Depression Among Breast Cancer Patients), which is not on this map. Cited by 111 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04219267 nacompletednot on this mapstarted 2020, after this paper: background citation

Effectiveness of Character Strengths-based Intervention in Enhancing Self-esteem, Quality of Life and Alleviating Depression Among Breast Cancer Patients: A Randomized Controlled Study

TypeinterventionalSponsorChinese University of Hong KongRan2020 to 2020Enrolled122ConditionsBreast CancerArmscharacter strengths-based intervention, early memories
3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 1 synthesis or guideline pooled it, 320 citations in OpenAlex.

  1. Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Pooled it
  2. Effectiveness of myofascial release after breast cancer surgery in women undergoing conservative surgery and radiotherapy: a randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Trial
  3. Trial
  4. Depression and family interaction among low-income, predominantly hispanic cancer patients: a longitudinal analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2014
    Trial
  5. Trial
  6. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2008
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Sleep quality and psychological disorders in breast cancer female patients receiving radiotherapy at a tertiary oncology center in West Saudi Arabia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kathleen EllDSW, School of Social Work-0411, University of Southern California, University Park, Los Angeles, CA 90089, USA. e-mail: ell@usc.edu
Kathleen Sanchez
Betsy Vourlekis
Pey-Jiuan Lee
Megan Dwight-Johnson
Isabel Lagomasino
Laila Muderspach
Christy Russell
University of Washington · USUniversity of Maryland, Baltimore · USUniversity of Southern California · US

Funding

Improving Patient Adherence to Cancer TreatmentR01CA094827 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ELL, KATHLEEN R · 2001 to 2004
$2.3M
NCI NIH HHS R01 CA094827NCI NIH HHS R01 CA94827-01
6 · The paper itself

Abstract

purposeTo assess the prevalence of depression among low-income, ethnic minority women with breast or gynecologic cancer, receipt of antidepressant medications or counseling services, and correlates of depression. PATIENTS AND

methodsStudy patients were 472 women receiving cancer care in an urban public medical center. Women had a primary diagnosis of breast (stage 0 to III) or gynecologic cancer (International Federation of Gynecology and Obstetrics stage 0 to IIIB). A diagnostic depression screen and baseline questionnaire were administered before or during active treatment or during active follow-up. Self-report data were collected on receipt of depression treatment, use of supportive counseling, pain and receipt of pain medication, functional status and well-being, and perceived barriers to cancer care.

resultsTwenty-four percent of women reported moderate to severe levels of depressive disorder (30% of breast cancer patients and 17% of gynecologic cancer patients). Only 12% of women meeting criteria for major depression reported currently receiving medications for depression, and only 5% of women reported seeing a counselor or participating in a cancer support group. Neither cancer stage nor treatment status was correlated with depression. Primary diagnosis of breast cancer, younger age, greater functional impairment, poorer social and family well-being, anxiety, comorbid arthritis, and fears about treatment side effects were correlated with depression.

conclusionFindings indicate that depressive disorder among ethnic minority, low-income women with breast or gynecologic cancer is prevalent and is correlated with pain, anxiety, and health-related quality of life. Because these women are unlikely to receive depression treatment or supportive counseling, there is a need for routine screening, evaluation, and treatment in this population.

Indexed as

AdultAntidepressive AgentsBreast NeoplasmsCase ManagementCounselingDepressionEthnicityFemaleGenital Neoplasms, FemaleHumansMiddle AgedMinority GroupsPovertyPrevalenceSeverity of Illness IndexUrban PopulationAntidepressive Agents

Identifiers

PMID15860863
PMCPMC1460295
OpenAlexW2136833425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.